Beta Bionics, Inc.
BBNX
$10.20
$0.303.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 57.87% | 53.94% | 67.01% | 97.91% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 57.87% | 53.94% | 67.01% | 97.91% | -- |
| Cost of Revenue | 46.82% | 52.94% | 69.47% | 101.37% | -- |
| Gross Profit | 67.30% | 54.75% | 65.00% | 95.05% | -- |
| SG&A Expenses | 61.06% | 68.19% | 71.45% | 85.32% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.92% | 55.77% | 67.88% | 80.64% | -- |
| Operating Income | -42.01% | -58.41% | -69.03% | -62.89% | -- |
| Income Before Tax | 6.38% | -33.68% | -40.27% | -34.77% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.38% | -33.68% | -40.27% | -34.77% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.38% | -33.68% | -40.27% | -34.77% | -- |
| EBIT | -42.01% | -58.41% | -69.03% | -62.89% | -- |
| EBITDA | -41.64% | -58.98% | -71.01% | -64.83% | -- |
| EPS Basic | 79.79% | 77.34% | 51.64% | 40.72% | -- |
| Normalized Basic EPS | 79.79% | 77.34% | 51.65% | 40.72% | -- |
| EPS Diluted | 79.79% | 77.34% | 51.64% | 40.72% | -- |
| Normalized Diluted EPS | 79.79% | 77.34% | 51.65% | 40.72% | -- |
| Average Basic Shares Outstanding | 250.28% | 536.19% | 401.32% | 276.58% | -- |
| Average Diluted Shares Outstanding | 250.28% | 536.19% | 401.32% | 276.58% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |